Home LiteratureArticle Details
PMID: 2200888 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA.

Journal of virology ·Vol. 64 ·No. 9 ·1990-09-00 ·Pages 4428-37

Dillon PJ, Nelbock P, Perkins A, Rosen CA

Abstract

The interaction of the human immunodeficiency virus type 1 (HIV-1) Rev protein with a structured region in env mRNA (the Rev-responsive element [RRE]) mediates the export of structural mRNAs from the nucleus to the cytoplasm. We demonstrated that unlike HIV-1 Rev, which functions with both the HIV-1 and HIV-2 RREs, HIV-2 Rev functions only with the HIV-2 RRE. Rev-RRE binding studies suggested that the lack of nonreciprocal complementation stems from the inability of HIV-2 Rev to interact with HIV-1 RRE RNA. Maintenance of RNA secondary structure, rather than the primary nucleotide sequence, appeared to be the major determinant for interaction of both HIV-1 and HIV-2 Rev with the HIV-2 RRE. Moreover, the binding domain of the HIV-2 RRE recognized by HIV-1 Rev was dissimilar to the binding domain of the HIV-1 RRE, in terms of both secondary structure and primary nucleotide sequence. Our results support the hypothesis that function of HIV Rev proteins and possibly the functionally similar Rex proteins encoded by the human T-cell leukemia viruses (HTLVs) HTLV-I and HTLV-II is controlled by the presence of RNA secondary structure generated within the RRE RNA.

MeSH Terms
Base Sequence Binding Sites Chromosome Deletion Cloning, Molecular Escherichia coli/genetics Gene Products, rev/genetics,isolation & purification,metabolism Genes, Viral Genetic Vectors HIV-1/genetics HIV-2/genetics Models, Molecular Molecular Sequence Data Mutation Nucleic Acid Conformation Protein Binding RNA, Messenger/genetics,metabolism Recombinant Proteins/isolation & purification,metabolism Restriction Mapping Simian Immunodeficiency Virus/genetics Trans-Activators/metabolism Viral Envelope Proteins/genetics rev Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, rev RNA, Messenger Recombinant Proteins Trans-Activators Viral Envelope Proteins rev Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Dillon P J
Department of Molecular Oncology and Virology, Roche Research Center, Nutley, New Jersey 07110-1199.
Nelbock P
Perkins A
Rosen C A
References (38)
38 references, click to expand
  1. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
    Science. 1985 Jul 5;229(4708):74-7 PMID: 2990041
  2. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
    Science. 1985 Dec 20;230(4732):1350-4 PMID: 2999980
  3. The trans-activator gene of HTLV-III is essential for virus replication.
    Nature. 1986 Mar 27-Apr 2;320(6060):367-71 PMID: 3007995
  4. A second post-transcriptional trans-activator gene required for HTLV-III replication.
    Nature. 1986 May 22-28;321(6068):412-7 PMID: 3012355
  5. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
    Cell. 1986 Sep 12;46(6):807-17 PMID: 3638988
  6. Genome organization and transactivation of the human immunodeficiency virus type 2.
    Nature. 1987 Apr 16-22;326(6114):662-9 PMID: 3031510
  7. The art gene product of human immunodeficiency virus is required for replication.
    J Virol. 1988 Feb;62(2):655-8 PMID: 3257271
  8. The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.
    EMBO J. 1987 Dec 1;6(12):3755-60 PMID: 2828036
  9. A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo.
    Methods Enzymol. 1987;155:416-33 PMID: 2828874
  10. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
    Science. 1988 Jan 29;239(4839):487-91 PMID: 2448875
  11. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1988 Apr;85(7):2071-5 PMID: 2832844
  12. HIV-1 tat trans-activation requires the loop sequence within tar.
    Nature. 1988 Jul 14;334(6178):165-7 PMID: 3386755
  13. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.
    Nature. 1988 Oct 20;335(6192):738-40 PMID: 3262832
  14. Structural and functional characterization of human immunodeficiency virus tat protein.
    J Virol. 1989 Jan;63(1):1-8 PMID: 2535718
  15. Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.
    J Acquir Immune Defic Syndr. 1988;1(5):441-52 PMID: 2851651
  16. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.
    J Virol. 1989 Mar;63(3):1265-74 PMID: 2783738
  17. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.
    Proc Natl Acad Sci U S A. 1989 Feb;86(3):821-4 PMID: 2536934
  18. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Nature. 1989 Mar 16;338(6212):254-7 PMID: 2784194
  19. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1495-9 PMID: 2784208
  20. Regulation of human immunodeficiency virus env expression by the rev gene product.
    J Virol. 1989 May;63(5):1959-66 PMID: 2704072
  21. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization.
    Cell. 1989 Jun 30;57(7):1155-65 PMID: 2736624
  22. HTLV-1 rex and HIV-1 rev act through similar mechanisms to relieve suppression of unspliced RNA expression.
    Oncogene. 1989 Nov;4(11):1275-9 PMID: 2682457
  23. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.
    Proc Natl Acad Sci U S A. 1989 Nov;86(21):8222-6 PMID: 2682638
  24. Purification of biologically active human immunodeficiency virus rev protein from Escherichia coli.
    Virology. 1989 Nov;173(1):335-7 PMID: 2683363
  25. Sequence-specific RNA binding by the HIV-1 Rev protein.
    Nature. 1989 Dec 7;342(6250):714-6 PMID: 2556643
  26. Functional analysis of CAR, the target sequence for the Rev protein of HIV-1.
    Science. 1989 Dec 22;246(4937):1625-9 PMID: 2688093
  27. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Nature. 1989 Dec 14;342(6251):816-9 PMID: 2481237
  28. Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function.
    J Virol. 1990 Feb;64(2):881-5 PMID: 2404140
  29. Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements.
    Genes Dev. 1989 Oct;3(10):1534-44 PMID: 2482226
  30. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA.
    Proc Natl Acad Sci U S A. 1990 Feb;87(3):1198-202 PMID: 2405396
  31. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.
    Cell. 1990 Feb 23;60(4):675-83 PMID: 2406030
  32. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region.
    Cell. 1990 Feb 23;60(4):685-93 PMID: 1689218
  33. Secondary structure is the major determinant for interaction of HIV rev protein with RNA.
    Science. 1990 Feb 16;247(4944):845-8 PMID: 2406903
  34. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  35. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 PMID: 3881765
  36. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
    Cell. 1985 Jul;41(3):813-23 PMID: 2988790
  37. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Jul 5;229(4708):69-73 PMID: 2990040
  38. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
    Cell. 1986 Mar 28;44(6):941-7 PMID: 2420471
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1990-09-00
Pages
4428-37
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC247912
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]